News

Nova Eye to Feature Several Presentations and Posters Related to iTrack Canaloplasty at 2024 ESCRS Annual Congress

Media Release General iTrack Molteno3 AlphaRET

2 Aug, 2024

iTrack™ Canaloplasty to be Featured at the 2024 Women in Ophthalmology (WIO) Summer Symposium

Media Release General iTrack Molteno3 AlphaRET

24 July, 2024

iTrack™ Canaloplasty to be Featured at the 2024 World Ophthalmology Congress (WOC)

Media Release General iTrack Molteno3 AlphaRET

24 July, 2024

iTrack™ Canaloplasty to be Featured in 31 Presentations in the Official 2024 ASCRS Annual Meeting

Media Release General iTrack Molteno3 AlphaRET

22 Mar, 2024

iTrack™ Canaloplasty to be Featured at the 2024 American Glaucoma Society (AGS) Annual Meeting

Media Release General iTrack Molteno3 AlphaRET

23 Jan, 2024

iTrack™ Advance Real-World Registry Data and CATALYST Study Data to be Presented at the 2023 ESCRS Annual Congress, Vienna

Media Release General iTrack Molteno3 AlphaRET

1 Sept, 2023

iTrack™ Canaloplasty to be Featured at the Congress of German Ophthalmic Surgery (DOC) 2023

Media Release General iTrack Molteno3 AlphaRET

15 June, 2023

Nova Eye Medical Launches Next Generation Canaloplasty Device for Glaucoma, iTrack™ Advance

Media Release General iTrack

19 Apr, 2022

iTrack™ Canaloplasty to be Featured at the 2022 ASCRS Annual Meeting

Media Release General iTrack

12 Apr, 2022

Nova Eye, Inc., President Appointed to American Glaucoma Society (AGS) Foundation Advisory Board

Media Release General iTrack

31 Mar, 2022

One Year Evaluation of Endothelial Cell Density Following iTrack™ to be Spotlighted at ESCRS 2021

Media Release General iTrack

8 Oct, 2021

5-Year Effectiveness and Safety Data for iTrack™ to be Spotlighted at ESCRS 2021

Media Release General iTrack

8 Oct, 2021

Long-Term Effectiveness of iTrack™ MIGS Procedure to be Spotlighted at 2021 Swiss Society of Ophthalmology

Media Release General iTrack

25 Aug, 2021

2RT® Featured at the 2021 Meeting of the Association for Research in Vision and Ophthalmology (ARVO)

Media Release General AlphaRET

3 May, 2021

Nova Eye Medical Announces First Patient Enrolled in “MAGIC” Multi-Center Canaloplasty Trial for Glaucoma

Media Release General iTrack

30 Apr, 2021

24-Month iTrack™ Data Demonstrate Real-World Efficacy of Canaloplasty as Standalone and Combined MIGS Procedure

Media Release General iTrack

20 Apr, 2021

Positive Five-Year Post-LEAD Trial Results for 2RT®

Media Release General AlphaRET

5 Mar, 2021

iTrack™ MIGS Procedure to Feature at the American Glaucoma Society (AGS) 2021 Virtual Meeting

Media Release General iTrack

4 Mar, 2021

Prospective Multi-Center Trial to Compare Efficacy and Safety Outcomes of Ab-Interno Canaloplasty for Glaucoma

Media Release General iTrack

2 Mar, 2021

iTrack™ to Feature at Australian and New Zealand Glaucoma Society (ANZGS) 2021 Meeting

Media Release General iTrack

19 Feb, 2021

iTrack™ Under Assessment for Public Funding via Australian Government’s Medical Benefit Scheme

Media Release General iTrack

18 Feb, 2021

iTrack™ MIGS Procedure Under Assessment for Public Funding via the Australian Government’s Medical Benefit Scheme

Media Release General iTrack

18 Feb, 2021

For media enquires please contact:

Kate Hunt
Nova Eye Medical Limited
W +61 404 080 679
khunt@nova-eye.com

This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More